ADCI NMDA antagonist and use-dependent voltage-gated sodium channel blocker: Phase I Update

Neurogen Corp. (NRGN), Branford, Conn.
Product: ADCI NMDA

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE